[Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases]
- PMID: 16597407
- DOI: 10.1051/medsci/2006224381
[Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases]
Abstract
The 5' AMP-activated protein kinase (AMPK) is a sensor of cellular energy homeostasis well conserved in all eukaryotic cells. AMPK is activated by rising AMP and falling ATP, either by inhibiting ATP production or by accelerating ATP consumption, by a complex mechanism that results in an ultrasensitive response. AMPK is a heterotrimeric enzyme complex consisting of a catalytic subunit alpha and two regulatory subunits beta and gamma. AMP activates the system by binding to the gamma subunit that triggers phosphorylation of the catalytic alpha subunit by the upstream kinases LKB1 and CaMKKbeta. Once activated, it switches on catabolic pathways (such as fatty acid oxidation and glycolysis) and switches off ATP-consuming pathways (such as lipogenesis) both by short-term effect on phosphorylation of regulatory proteins and by long-term effect on gene expression. Dominant mutations in the regulatory gamma subunit isoforms cause hypertrophy of cardiac and skeletal muscle providing a link in human diseases caused by defects in energy metabolism. As well as acting at the level of the individual cell, the system also regulates food intake and energy expenditure at the whole body level, in particular by mediating the effects of adipokines such as leptin and adiponectin. Moreover, the AMPK system is one of the probable target for the anti-diabetic drug metformin and rosiglitazone. The relationship between AMPK activation and beneficial metabolic effects provides the rationale for the development of new therapeutic strategies. Thus, pharmacological AMPK activation may, through signaling, metabolic and gene expression effects, reduce the risk of Type 2 diabetes, metabolic syndrome and cardiac diseases.
Similar articles
-
Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.Diabetes Metab. 2007 Dec;33(6):395-402. doi: 10.1016/j.diabet.2007.10.004. Epub 2007 Nov 7. Diabetes Metab. 2007. PMID: 17997341 Review.
-
AMP-activated protein kinase in metabolic control and insulin signaling.Circ Res. 2007 Feb 16;100(3):328-41. doi: 10.1161/01.RES.0000256090.42690.05. Circ Res. 2007. PMID: 17307971 Review.
-
[AMPK as a cellular energy sensor and its function in the organism].Rev Invest Clin. 2007 Nov-Dec;59(6):458-69. Rev Invest Clin. 2007. PMID: 18402338 Review. Spanish.
-
AMP-activated protein kinase: structure and regulation.Curr Protein Pept Sci. 2008 Oct;9(5):478-92. doi: 10.2174/138920308785915254. Curr Protein Pept Sci. 2008. PMID: 18855699 Review.
-
[AMP-activated protein kinase--the key role in metabolic regulation].Postepy Biochem. 2006;52(3):283-8. Postepy Biochem. 2006. PMID: 17201063 Review. Polish.
Cited by
-
Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis.Oncotarget. 2015 Aug 28;6(25):20993-1003. doi: 10.18632/oncotarget.3663. Oncotarget. 2015. PMID: 25895130 Free PMC article.
-
Antidiabetic and Antihyperlipidemic Effects of Clitocybe nuda on Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.Evid Based Complement Alternat Med. 2014;2014:981046. doi: 10.1155/2014/981046. Epub 2014 Jan 16. Evid Based Complement Alternat Med. 2014. PMID: 24550994 Free PMC article.
-
Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.Int J Mol Sci. 2014 Nov 4;15(11):20022-44. doi: 10.3390/ijms151120022. Int J Mol Sci. 2014. PMID: 25375187 Free PMC article.
-
Roles of AMP-activated protein kinase in Alzheimer's disease.Neuromolecular Med. 2012 Mar;14(1):1-14. doi: 10.1007/s12017-012-8173-2. Epub 2012 Feb 26. Neuromolecular Med. 2012. PMID: 22367557 Review.
-
YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.Nutrients. 2016 Sep 23;8(10):546. doi: 10.3390/nu8100546. Nutrients. 2016. PMID: 27669292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials